These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7840376)

  • 1. Anxiety sensitivity and cholecystokinin tetrapeptide challenge.
    McNally RJ
    Am J Psychiatry; 1995 Feb; 152(2):300-1. PubMed ID: 7840376
    [No Abstract]   [Full Text] [Related]  

  • 2. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
    Koszycki D; Cox BJ; Bradwejn J
    Am J Psychiatry; 1993 Dec; 150(12):1881-3. PubMed ID: 8238648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.
    Bradwejn J; Koszycki D
    Am J Psychiatry; 1994 Feb; 151(2):261-3. PubMed ID: 8296900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trait dissociation affects the behavioral response to cholecystokinin tetrapeptide in healthy man.
    Kellner M; Yassouridis A; Hua Y; Wendrich M; Naber D; Wiedemann K
    Psychiatry Res; 2002 Aug; 111(1):93-6. PubMed ID: 12140124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of state and trait anxiety on the panic response to CCK-4.
    Eser D; Wenninger S; Baghai T; Schüle C; Rupprecht R
    J Neural Transm (Vienna); 2008 Jun; 115(6):917-20. PubMed ID: 18414777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.
    Tõru I; Aluoja A; Võhma U; Raag M; Vasar V; Maron E; Shlik J
    Psychiatry Res; 2010 Jul; 178(2):342-7. PubMed ID: 20471107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings.
    Bradwejn J; Koszycki D; Payeur R; Bourin M; Borthwick H
    Am J Psychiatry; 1992 Jul; 149(7):962-4. PubMed ID: 1609879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholecystokinin hypothesis of anxiety and panic disorder.
    Bradwejn J; Koszycki D
    Ann N Y Acad Sci; 1994 Mar; 713():273-82. PubMed ID: 8185169
    [No Abstract]   [Full Text] [Related]  

  • 9. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks.
    Eser D; Uhr M; Leicht G; Asmus M; Länger A; Schüle C; Baghai TC; Mulert C; Rupprecht R
    J Psychiatr Res; 2011 Jan; 45(1):60-3. PubMed ID: 20542521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.
    Aluoja A; Shlik J; Vasar V; Kingisepp PH; Jagomägi K; Vasar E; Bradwejn J
    Psychiatry Res; 1997 Jan; 66(1):59-67. PubMed ID: 9061804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
    Ströhle A; Kellner M; Holsboer F; Wiedemann K
    Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide.
    Le Melledo JM; Bradwejn J; Koszycki D; Bichet D
    Arch Gen Psychiatry; 1995 Jul; 52(7):605-6. PubMed ID: 7598637
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia.
    Akiyoshi J; Isogawa K; Tsutsumi T; Kasturagi S; Kohno K; Furuta M; Yamamoto Y; Yamada K; Fujii I
    Biol Psychiatry; 1997 Jul; 42(2):151-4. PubMed ID: 9209734
    [No Abstract]   [Full Text] [Related]  

  • 14. Provocation of a posttraumatic flashback by cholecystokinin tetrapeptide?
    Kellner M; Levengood R; Yehuda R; Wiedemann K
    Am J Psychiatry; 1998 Sep; 155(9):1299. PubMed ID: 9734561
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of oral ondansetron on total cholecystokinin plasma levels following CCK-4 panic challenge procedure in healthy men.
    Dépôt M; Merani S; Bradwejn J; Mukherjee J; Caillé J; Gutkowska J; Caillé G
    J Psychiatry Neurosci; 1998 Nov; 23(5):298-304. PubMed ID: 9846035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute antipanic activity of aerobic exercise.
    Ströhle A; Feller C; Onken M; Godemann F; Heinz A; Dimeo F
    Am J Psychiatry; 2005 Dec; 162(12):2376-8. PubMed ID: 16330604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
    Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A
    J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
    Schunck T; Erb G; Mathis A; Gilles C; Namer IJ; Hode Y; Demaziere A; Luthringer R; Macher JP
    Neuroimage; 2006 Jul; 31(3):1197-208. PubMed ID: 16600640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCK-B receptor gene and response to cholecystokinin-tetrapeptide in healthy volunteers.
    Koszycki D; Prichard Z; Fiocco AJ; Shlik J; Kennedy JL; Bradwejn J
    Peptides; 2012 May; 35(1):9-13. PubMed ID: 22414867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.